$CTMX CytomX Therapeutics, Inc. Insider Trading
Get free email notifications about insider trading in CytomX Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in CytomX Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in CytomX Therapeutics, Inc. for free.
CIK Number: 0001501989
IRS Number: 273521219
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: CTMX
Company Address: 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO 94080
Phone number: 650.515.3185
Market Capitalization: $410.61M
Prev close: $11.50
Average Daily Volume: 126,577
Days Low: $11.20
Year Low: $9.10
Year High: $17.79
CytomX Therapeutics, Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 21 2021 | CTMX | CytomX Therapeutic ... | McCarthy Sean A. | President and CEO | Sell | S | 7.04 | 100,000 | 704,470 | 93,118 | 193.1 K to 93.1 K (-51.78 %) |
Jun 17 2021 | CTMX | CytomX Therapeutic ... | Young Matthew P. | Director | Option Exercise | A | 7.13 | 20,000 | 142,600 | 20,000 | |
Jun 17 2021 | CTMX | CytomX Therapeutic ... | Jones Elaine V | Director | Option Exercise | A | 7.13 | 20,000 | 142,600 | 20,000 | |
Jun 08 2021 | CTMX | CytomX Therapeutic ... | Campoy Carlos | Chief Financial Off ... | Grant | A | 6.09 | 3,320 | 20,206 | 6,421 | 3.1 K to 6.4 K (+107.06 %) |
Apr 02 2021 | CTMX | CytomX Therapeutic ... | McCarthy Sean A. | President and CEO | Option Exercise | M | 1.13 | 100,000 | 113,390 | 92,143 | |
Apr 02 2021 | CTMX | CytomX Therapeutic ... | McCarthy Sean A. | President and CEO | Sell | S | 7.49 | 100,000 | 749,470 | 206,894 | 306.9 K to 206.9 K (-32.58 %) |
Apr 02 2021 | CTMX | CytomX Therapeutic ... | McCarthy Sean A. | President and CEO | Buy | M | 1.13 | 100,000 | 113,390 | 306,894 | 206.9 K to 306.9 K (+48.33 %) |
Mar 02 2021 | CTMX | CytomX Therapeutic ... | Peterson Amy C. | EVP, Chief Developm ... | Option Exercise | A | 7.85 | 250,000 | 1,962,500 | 250,000 | |
Mar 02 2021 | CTMX | CytomX Therapeutic ... | Campoy Carlos | Chief Financial Off ... | Option Exercise | A | 7.85 | 100,000 | 785,000 | 100,000 | |
Mar 02 2021 | CTMX | CytomX Therapeutic ... | HANNAH ALISON L. | Chief Medical Offic ... | Option Exercise | A | 7.85 | 175,000 | 1,373,750 | 175,000 | |
Mar 02 2021 | CTMX | CytomX Therapeutic ... | ROWLAND LLOYD A | General Counsel | Option Exercise | A | 7.85 | 125,000 | 981,250 | 125,000 | |
Mar 02 2021 | CTMX | CytomX Therapeutic ... | McCarthy Sean A. | President and CEO | Option Exercise | A | 7.85 | 200,000 | 1,570,000 | 200,000 | |
Mar 02 2021 | CTMX | CytomX Therapeutic ... | McCarthy Sean A. | President and CEO | Option Exercise | A | 7.85 | 400,000 | 3,140,000 | 400,000 | |
Dec 28 2020 | CTMX | CytomX Therapeutic ... | McCarthy Sean A. | President and CEO | Option Exercise | M | 1.13 | 100,000 | 113,390 | 192,143 | |
Dec 28 2020 | CTMX | CytomX Therapeutic ... | McCarthy Sean A. | President and CEO | Buy | M | 1.13 | 100,000 | 113,390 | 206,894 | 106.9 K to 206.9 K (+93.55 %) |